Once the rarified stuff of scientists and statisticians, data are now at the heart of our global digital economy, transforming everything from how we perceive the value of a professional athlete to the intelligence gathering activities of governments. We are told that the right data can turn an election, help predict crime, improve our businesses, our health and our capacity to make decisions. Beginning with a simple question – how do most people encounter and experience data? – Nathaniel Tkacz sets out on a path at odds with much of the contemporary discussion about data. When we encounter data, he contends, it is often in highly routinised ways, through formatted displays and for specific cognitive tasks. What data are and can do is largely a matter of how they are formatted. To understand our 'datafied' societies, we need to turn our attention to data's formats and the powers of formatting. This book offers an account of one such format: the dashboard. From their first appearance with the horse and carriage, Tkacz guides readers on the historical development of this format. Through analyses of car dashboards, early managerial dashboards, and the gradual emergence of dashboards as a computer display technology, Tkacz shows how today's digital dashboards came to be, and how their cultural history conditions the present. Highly original and wide-ranging, this book will change how you think about data.
Das Arbeitsbuch zum neuen «großen Atkins»!<br> <br> Der «große Atkins» ist und bleibt ein Muss für alle Studierenden, die sich ernsthaft mit der Physikalischen Chemie auseinandersetzen. In unverwechselbarem Stil deckt Peter Atkins mit seinen Koautoren Julio de Paula und James Keeler die gesamte Bandbreite dieses faszinierenden und herausfordernden Fachs ab.<br> <br> Das darauf abgestimmte Arbeitsbuch bietet die vollständigen Lösungen der leichteren "a"-Aufgaben und der schwereren Aufgaben sowie Musterantworten zu den ungeraden Diskussionsfragen.<br>
High-level commentary on various facets of the pharmaceutical industry from a key leader in the field This book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: Fiscal consequences of curing hepatitis C mRNA vaccines and the race for a cure Why the government does not deserve a piece of Biopharma’s profits Paying for drugs whose ultimate value is unknown The impact of reduced revenues on R&DThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.
Wieso schaffen nur 10% der gegründeten Unternehmen weltweit das wirtschaftliche Überleben? Weshalb fühlen sich immer mehr Unter-Dreißigjährige schon ausgelaugt? Warum liegt die Scheidungsrate international bei knapp 50%? <br> Die Antworten darauf liefert dieses Buch, das den gedanklichen Befreiungsschlag unternimmt, der viele Probleme lösen kann in Beziehungen, Firmen und Organisationen jeglicher Art. Der Weg führt über die innere Einstellung. Lebensglück und Erfolg sind damit untrennbar verbunden.<br> Ergänzt und untermauert wird der Mindset-Ansatz des Autors durch praktische, unterhaltsame und alarmierende Anekdoten aus seiner langjährigen Seminar- und Unterrichtspraxis in Firmen und Hochschulen – dort, wo die Menschen stark fremdbestimmt und ihr Denken sowie ihre Haltung entsprechend beeinflusst sind.<br>